Evidence map›Paper›PMID 34416115›Full record

ArticleVascular2022

Extensive deep vein thrombosis and pulmonary embolism as a unique clinical manifestation of COVID-19 in a young healthy patient.

Alejandro Llausas-Villarreal, Marycarmen Mendoza-Silva, Oliver Antonio Gómez-Gutiérrez, Mauricio Gonzalez-Urquijo, Mario Alejandro Fabiani

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Vascular, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Alejandro Llausas-VillarrealTecnologico de Monterrey, 27746 School of Medicine and Health Sciences, Nuevo Leon, Mexico.
Marycarmen Mendoza-SilvaTecnologico de Monterrey, 27746 School of Medicine and Health Sciences, Nuevo Leon, Mexico.ORCID 0000-0001-6651-2891
Oliver Antonio Gómez-GutiérrezTecnologico de Monterrey, 27746 School of Medicine and Health Sciences, Nuevo Leon, Mexico.
Mauricio Gonzalez-UrquijoTecnologico de Monterrey, 27746 School of Medicine and Health Sciences, Nuevo Leon, Mexico.
Mario Alejandro FabianiTecnologico de Monterrey, 27746 School of Medicine and Health Sciences, Nuevo Leon, Mexico.ORCID 0000-0002-8548-6833
Tecnológico de Monterrey · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

objectiveDeep vein thrombosis and pulmonary embolism have been described as complications in previously diagnosed COVID-19 patients, especially in those admitted in critical ill units, but, to our knowledge, there is no report of venous thromboembolism in an otherwise asymptomatic COVID-19 patient.

methodsWe report the case of a 22-year-old female, healthy patient with pulmonary embolism (Pulmonary Embolism Severity Index Score 22 points, low risk) and extensive proximal deep vein thrombosis as a unique clinical manifestation of the new coronavirus disease.

resultsThe patient had no risk factors and no familial history of venous thromboembolism. All thrombophilia markers were negative. The patient was treated as first by an independent vascular team, performing vena cava filter placement and open thrombectomy. Her symptoms worsened, and after 3 weeks, she underwent US-enhanced thrombolysis and mechanical thrombectomy. She was isolated for 10 days and did not develop any other clinical manifestation of COVID-19 disease. During follow-up, she remained asymptomatic and complete patency of the venous system was achieved. Full oral anticoagulation was conducted for 6 months.

conclusionCOVID-19 appears to be a multi-symptomatic disease, and venous thromboembolism without any other previous described COVID-19 symptom could be considered one of its diverse clinical presentations and RT-PCR for SARS-CoV-2 tests emerge to be mandatory in patients with otherwise unexpected venous thrombosis.

Indexed as

COVID-19Pulmonary EmbolismVena Cava FiltersVenous ThromboembolismVenous ThrombosisAdultAnticoagulantsFemaleHumansSARS-CoV-2Young AdultAnticoagulantsCOVID-19deep vein thrombosispulmonary embolismvenous thromboembolism

Identifiers

PMID34416115
PMCPMC8685733
OpenAlexW3193432121

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.